Clinical trial
Botulinum Toxin Type A Versus 0,9% Saline in Treatment of Cranial Allodynia in Patients With Headache
NCT01357798 is registered in ClinicalTrials.gov with Federal University of Bahia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Botulinum Toxin Type A Versus 0,9% Saline in Treatment of Cranial Allodynia in Patients With Headache
- Lead sponsor
- Federal University of Bahia
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- Not reported
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allodynia, headache